Literature DB >> 31967016

LOCALLY INVASIVE PHEOCHROMOCYTOMA COMBINED WITH PRIMARY MALIGNANT ADRENAL LYMPHOMA.

Omar H Oraibi, Laura I Wharry, Amy A Lynn, Foiqa Chaudhry, Juan C Jaume, John Y Jun.   

Abstract

OBJECTIVE: Pheochromocytoma (PHEO) combined with primary adrenal lymphoma is extremely rare. We describe a case of locally invasive PHEO combined with primary malignant lymphoma.
METHODS: We provide a case description with biochemical analyses, imaging, and pathologic findings.
RESULTS: A 79-year-old male presented with a 17-cm, complex mass in the left adrenal gland with non-contrast Hounsfield units of 100 and left para-aortic enlarged lymph nodes imaged by computed tomography. Biochemical evaluation showed plasma and 24-hour urinary normetanephrine significantly elevated about 22 times (about 13.5 times above the normal upper limit) while metanephrine levels were normal. With adequate perioperative preparation, en bloc resection of the left adrenal gland was performed. The pathology revealed a tumor consisting of B-cell lymphoma, a PHEO forming a large adrenal mass with soft tissue invasion with extensive sclerosis and a separate nodule with PHEO without sclerosis. Immunohistochemistry and in situ hybridization of the lymphoma were consistent with Epstein-Barr virus-positive, diffuse large B-cell lymphoma. Immunohistochemistry of the PHEO was positive for chromogranin, synaptophysin, and S100. The Ki67 index was 8.7% and PHEO of the adrenal gland scaled score was 8 (≥4 is considered potentially malignant).
CONCLUSION: To the best of our knowledge this is the first case demonstrating locally invasive and potentially malignant PHEO combined with primary malignant lymphoma in the same adrenal gland.
Copyright © 2019 AACE.

Entities:  

Year:  2018        PMID: 31967016      PMCID: PMC6873865          DOI: 10.4158/ACCR-2018-0221

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  17 in total

1.  Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Authors:  Graeme Eisenhofer; Karel Pacak; Thanh-Truc Huynh; Nan Qin; Gennady Bratslavsky; W Marston Linehan; Massimo Mannelli; Peter Friberg; Stefan K Grebe; Henri J Timmers; Stefan R Bornstein; Jacques W M Lenders
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

2.  N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.

Authors:  Helena Leijon; Tuomas Kaprio; Annamari Heiskanen; Tero Satomaa; Jukka O Hiltunen; Markku M Miettinen; Johanna Arola; Caj Haglund
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

3.  Expression of Contactin 4 Is Associated With Malignant Behavior in Pheochromocytomas and Paragangliomas.

Authors:  Lucie Evenepoel; Francien H van Nederveen; Lindsey Oudijk; Thomas G Papathomas; David F Restuccia; Eric J T Belt; Wouter W de Herder; Richard A Feelders; Gaston J H Franssen; Marc Hamoir; Dominique Maiter; Hans K Ghayee; Jerry W Shay; Aurel Perren; Henri J L M Timmers; Susanne van Eeden; Laurent Vroonen; Selda Aydin; Mercedes Robledo; Miikka Vikkula; Ronald R de Krijger; Winand N M Dinjens; Alexandre Persu; Esther Korpershoek
Journal:  J Clin Endocrinol Metab       Date:  2018-01-01       Impact factor: 5.958

Review 4.  Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma.

Authors:  K Pacak; W M Linehan; G Eisenhofer; M M Walther; D S Goldstein
Journal:  Ann Intern Med       Date:  2001-02-20       Impact factor: 25.391

5.  Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.

Authors:  Oksana Hamidi; William F Young; Nicole M Iñiguez-Ariza; Nana Esi Kittah; Lucinda Gruber; Cristian Bancos; Shrikant Tamhane; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

6.  Courses of malignant pheochromocytoma: implications for therapy.

Authors:  James C Sisson; Barry L Shulkin; Nazanene H Esfandiari
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

7.  Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.

Authors:  Lester D R Thompson
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

Review 8.  Primary adrenal lymphoma: a systematic review.

Authors:  Armin Rashidi; Stephen I Fisher
Journal:  Ann Hematol       Date:  2013-06-15       Impact factor: 3.673

9.  A case of primary unilateral adrenal Burkitt-like large cell lymphoma presenting as adrenal insufficiency.

Authors:  Ling Zhang; Sameer S Talwalkar; Saad Paul Shaheen
Journal:  Ann Diagn Pathol       Date:  2007-04       Impact factor: 2.090

10.  Bilateral primary adrenal lymphoma presenting with adrenal insufficiency.

Authors:  Jakob Holm; Leif Breum; Katrine Stenfeldt; Mette Friberg Hitz
Journal:  Case Rep Endocrinol       Date:  2012-09-04
View more
  1 in total

1.  A Novel Diagnostic Model for Primary Adrenal Lymphoma.

Authors:  Kai Yu; Qingping Xue; Fangli Zhou; Haoming Tian; Qiao Xiang; Tao Chen; Yan Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-02       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.